-+ 0.00%
-+ 0.00%
-+ 0.00%

Moleculin Biotech Q1 EPS $(0.69) Beats $(0.83) Estimate

Benzinga·05/13/2025 20:43:08
Listen to the news
Moleculin Biotech (NASDAQ:MBRX) reported quarterly losses of $(0.69) per share which beat the analyst consensus estimate of $(0.83) by 16.87 percent. This is a 65.84 percent increase over losses of $(2.02) per share from the same period last year.